Experimental and clinical study of the effect of artrofoon on proinflammatory cytokine production

M V Kachanova1, E Y Sherstoboyev, A R Babayeva

  • 1Materia Medica Holding Research-and-Production Company, Moscow. kachanovamv@materiamedica.ru

Insights

Artrofoon demonstrated anti-inflammatory effects in collagen-induced arthritis in mice and rheumatoid arthritis patients. It significantly reduced key inflammatory markers, tumor necrosis factor-alpha and interleukin-1beta.

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Rheumatoid arthritis is a chronic inflammatory autoimmune disease.
  • Proinflammatory cytokines like TNF-α and IL-1β play a key role in RA pathogenesis.
  • Developing effective anti-inflammatory treatments remains a priority.

Purpose of the Study:

  • To evaluate the anti-inflammatory effects of Artrofoon.
  • To assess Artrofoon's impact on cytokine production in arthritis models.

Main Methods:

  • Collagen-induced arthritis model in mice.
  • Clinical study involving patients with rheumatoid arthritis.
  • Measurement of proinflammatory cytokines, including tumor necrosis factor-alpha and interleukin-1beta.

Main Results:

  • Artrofoon exhibited anti-inflammatory effects in mice with collagen-induced arthritis.
  • Artrofoon reduced clinical signs of inflammation in rheumatoid arthritis patients.
  • A significant decrease in tumor necrosis factor-alpha and interleukin-1beta production was observed.

Conclusions:

  • Artrofoon possesses anti-inflammatory properties relevant to arthritis treatment.
  • The therapeutic effect of Artrofoon is associated with the modulation of key proinflammatory cytokines.
  • Further investigation into Artrofoon for managing inflammatory conditions is warranted.